iShares U.S. Pharmaceuticals ETF – AMEX:IHE
iShares U.S. Pharmaceuticals ETF stock price today
$70.19
+3.81
+5.76%
Market closed
Open in about 6 hours
iShares U.S. Pharmaceuticals ETF stock price monthly change
-3.28%
month
iShares U.S. Pharmaceuticals ETF stock price quarterly change
-3.28%
quarter
iShares U.S. Pharmaceuticals ETF stock price yearly change
-64.23%
year
iShares U.S. Pharmaceuticals ETF key metrics
Market Cap | 611.35M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeiShares U.S. Pharmaceuticals ETF stock price history
iShares U.S. Pharmaceuticals ETF stock forecast
iShares U.S. Pharmaceuticals ETF financial statements
iShares U.S. Pharmaceuticals ETF other data
Week In Review: China Biopharmas Book $9B In Deals During JP Morgan Conference Week
Horiba: Wonderful Japanese Company At A Very Attractive Price
Johnson & Johnson: EPS Growth Returns In 2024, JPM Healthcare Conference On Tap
Week In Review: 2024 Kicks Off With 3 Deals Worth A Total Of $4B
Pfizer: Sell-Off Overdone, Healthy Pipeline To Sustain Above 15% ROE
Week In Review: Novartis In $1 Billion Deal For DTx Pharma
Merck Is Poised To Outperform In 2023
Eli Lilly: What To Do When The Market Doesn't Care About Valuation
What To Do After EU Hits Teva With Antitrust Concerns
-
What's the price of iShares U.S. Pharmaceuticals ETF stock today?
One share of iShares U.S. Pharmaceuticals ETF stock can currently be purchased for approximately $70.19.
-
When is iShares U.S. Pharmaceuticals ETF's next earnings date?
Unfortunately, iShares U.S. Pharmaceuticals ETF's (IHE) next earnings date is currently unknown.
-
Does iShares U.S. Pharmaceuticals ETF pay dividends?
Yes, iShares U.S. Pharmaceuticals ETF pays dividends and its trailing 12-month yield is 1.55% with 0% payout ratio. The last iShares U.S. Pharmaceuticals ETF stock dividend of $0.79 was paid on 25 Sep 2025.
-
How much money does iShares U.S. Pharmaceuticals ETF make?
iShares U.S. Pharmaceuticals ETF has a market capitalization of 611.35M.
-
What is iShares U.S. Pharmaceuticals ETF's stock symbol?
iShares U.S. Pharmaceuticals ETF is traded on the AMEX under the ticker symbol "IHE".
-
What is iShares U.S. Pharmaceuticals ETF's primary industry?
Company operates in the Financial Services sector and Asset Management industry.
-
How do i buy shares of iShares U.S. Pharmaceuticals ETF?
Shares of iShares U.S. Pharmaceuticals ETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When iShares U.S. Pharmaceuticals ETF went public?
iShares U.S. Pharmaceuticals ETF is publicly traded company for more then 19 years since IPO on 5 May 2006.
iShares U.S. Pharmaceuticals ETF company profile:
Exchange:
AMEX
Full time employees:
0
Industry:
Asset Management
Sector:
Financial Services
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.
,
CIK: 0001100663
ISIN: US4642888360
CUSIP: 464288836
